Rodenhuis S - Search Results

1

Reinfusion of autologous lymphocytes with granulocyte-macrophage colony-stimulating factor induces rapid recovery of CD4+ and CD8+ T cells after high-dose chemotherapy for metastatic breast cancer.

de Gast GC, Vyth-Dreese FA, Nooijen W, van den Bogaard CJ, Sein J, Holtkamp MM, Linthorst GA, Baars JW, Schornagel JH, Rodenhuis S. de Gast GC, et al. Among authors: rodenhuis s. J Clin Oncol. 2002 Jan 1;20(1):58-64. doi: 10.1200/JCO.2002.20.1.58. J Clin Oncol. 2002. PMID: 11773154 Clinical Trial.

2

Feasibility and toxicity study of a high-dose chemotherapy regimen for autotransplantation incorporating carboplatin, cyclophosphamide and thiotepa.

Rodenhuis S, Baars JW, Schornagel JH, Vlasveld LT, Mandjes I, Pinedo HM, Richel DJ. Rodenhuis S, et al. Ann Oncol. 1992 Dec;3(10):855-60. doi: 10.1093/oxfordjournals.annonc.a058111. Ann Oncol. 1992. PMID: 1286049 Free article. Clinical Trial.

3

Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft size.

van der Wall E, Richel DJ, Holtkamp MJ, Slaper-Cortenbach IC, van der Schoot CE, Dalesio O, Nooijen WJ, Schornagel JH, Rodenhuis S. van der Wall E, et al. Among authors: rodenhuis s. Ann Oncol. 1994 Nov;5(9):795-802. doi: 10.1093/oxfordjournals.annonc.a059007. Ann Oncol. 1994. PMID: 7531486 Free article.

4

Feasibility study of FEC-chemotherapy with dose-intensive epirubicin as initial treatment in high-risk breast cancer.

van der Wall E, Richel DJ, Kusumanto YH, Rutgers EJ, Schornagel JH, Schaake-Koning CC, Peterse JL, Rodenhuis S. van der Wall E, et al. Among authors: rodenhuis s. Ann Oncol. 1993 Nov;4(9):791-2. doi: 10.1093/oxfordjournals.annonc.a058667. Ann Oncol. 1993. PMID: 8280661 Free article.

5

Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancer.

Rodenhuis S, Westermann A, Holtkamp MJ, Nooijen WJ, Baars JW, van der Wall E, Slaper-Cortenbach IC, Schornagel JH. Rodenhuis S, et al. J Clin Oncol. 1996 May;14(5):1473-83. doi: 10.1200/JCO.1996.14.5.1473. J Clin Oncol. 1996. PMID: 8622061 Clinical Trial.

6

Efficacy of up-front 5-fluorouracil-epidoxorubicin-cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients.

van der Wall E, Rutgers EJ, Holtkamp MJ, Baars JW, Schornagel JH, Peterse JL, Beijnen JH, Rodenhuis S. van der Wall E, et al. Among authors: rodenhuis s. Br J Cancer. 1996 May;73(9):1080-5. doi: 10.1038/bjc.1996.208. Br J Cancer. 1996. PMID: 8624267 Free PMC article. Clinical Trial.

7

Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement.

Rodenhuis S, Richel DJ, van der Wall E, Schornagel JH, Baars JW, Koning CC, Peterse JL, Borger JH, Nooijen WJ, Bakx R, Dalesio O, Rutgers E. Rodenhuis S, et al. Lancet. 1998 Aug 15;352(9127):515-21. doi: 10.1016/S0140-6736(98)01350-6. Lancet. 1998. PMID: 9716055 Clinical Trial.

8

At home management of aplastic phase following high-dose chemotherapy with stem-cell rescue for hematological and non-hematological malignancies.

Westermann AM, Holtkamp MM, Linthorst GA, van Leeuwen L, Willemse EJ, van Dijk WC, Nooijen WJ, Baars JW, Schornagel JH, Rodenhuis S. Westermann AM, et al. Among authors: rodenhuis s. Ann Oncol. 1999 May;10(5):511-7. doi: 10.1023/a:1026427724108. Ann Oncol. 1999. PMID: 10415999 Free article.

9

Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer.

Schrama JG, Baars JW, Holtkamp MJ, Schornagel JH, Beijnen JH, Rodenhuis S. Schrama JG, et al. Among authors: rodenhuis s. Bone Marrow Transplant. 2001 Jul;28(2):173-80. doi: 10.1038/sj.bmt.1703105. Bone Marrow Transplant. 2001. PMID: 11509935 Clinical Trial.

10

Randomized trial of high-dose chemotherapy and hematopoietic progenitor-cell support in operable breast cancer with extensive lymph node involvement: final analysis with 7 years of follow-up.

Schrama JG, Faneyte IF, Schornagel JH, Baars JW, Peterse JL, van de Vijver MJ, Dalesio O, van Tinteren H, Rutgers EJ, Richelt DJ, Rodenhuis S. Schrama JG, et al. Among authors: rodenhuis s. Ann Oncol. 2002 May;13(5):689-98. doi: 10.1093/annonc/mdf203. Ann Oncol. 2002. PMID: 12075736 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters